2q 2011 European Update

Embed Size (px)

Citation preview

  • 7/31/2019 2q 2011 European Update

    1/47

    European Quarterly Update

    Second Quarter 2011

    GMO offers a range of strategies orientated towardsinstitutional investors investing in equities and fixed income inthe developed international and emerging markets.

    ContentsEuropean Market Review ............................................................. 4

    Asset Allocation ............................................................................. 4

    Performance Review and Outlook ............................................. 6

    Strategy Performance Details..................................................... 16

    Table of Benchmarks .................................................................. 45

  • 7/31/2019 2q 2011 European Update

    2/47

    2 GMO European Quarterly Update

    2011 Performance of GMO Strategies and Benchmarks

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction ofmanagement fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assumethe reinvestment of dividends and other income. A GIPS compliant presentation is available at www.gmo.com.

    Copyright 2011 by GMO. All rights reserved. This document may not be reproduced, distributed or transmitted, in whole or in portion, by anymeans, without written permission from GMO.

    * Returns for one of the accounts in the composite are based on estimated market values for the period from and including October 2008 through February 2009.** Returns for the composite are based on estimated market values for the period from and including October 2008 through February 2009.

    Total Return Net of Fees Aver age Annual Total Return

    GMO Equity Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date Currency 2011 2011 Added Year Year Year Inception

    Global Equity 7/31/96 USD 1.89 6.66 1.37 30.91 1.57 5.68 7.31

    MSCI World 0.47 5.29 30.51 2.28 3.99 5.65

    World ex-UK Equity 12/31/88 GBP 1.01 3.41 0.82 21.43 5.49 4.64 9.25FTSE World ex-UK 0.30 2.59 22.14 6.85 3.77 7.34

    International Intrinsic Value 3/31/87 USD 2.68 6.94 1.37 31.34 0.72 8.13 8.57

    MSCI EAFE Value 0.98 5.58 29.35 0.36 5.96 7.36

    MSCI EAFE 1.56 4.98 30.36 1.48 5.66 5.41

    International Core Equity 1/31/02 USD 3.51 7.31 2.33 34.25 1.74 n/a 9.33

    MSCI EAFE 1.56 4.98 30.36 1.48 n/a 7.59

    Japan Equity 12/31/05 USD 3.41 1.85 5.83 21.15 -1.14 n/a -0.88

    MSCI Japan IMI++ 0.48 -3.97 13.43 -3.24 n/a -2.62

    Emerging Markets 12/31/93 USD -1.48 3.15 2.46 33.25 9.57 17.72 9.99

    S&P/IFCI Composite -0.98 0.70 28.61 12.06 17.53 7.30

    MSCI Emerging Markets -1.15 0.88 27.80 11.42 16.20 6.74

    UK Equity Core 11/30/04 GBP 2.70 3.80 0.84 25.64 3.98 n/a 8.43FTSE All-Share 1.91 2.96 25.63 4.49 n/a 8.00

    UK Equity Value 11/30/88 GBP 3.53 4.52 1.56 27.13 2.87 5.54 10.08

    FTSE All-Share 1.91 2.96 25.63 4.49 4.76 9.36

    U.S. Core 9/30/85 USD 2.85 7.40 1.37 29.74 2.24 2.05 10.93

    S&P 500 0.10 6.02 30.69 2.94 2.72 10.57

    Intrinsic Value 5/31/99 USD 1.86 10.35 4.43 36.15 0.97 2.90 3.81

    Russell 1000 Value -0.50 5.92 28.94 1.15 3.99 3.57

    Quality 2/29/04 USD 3.42 7.02 0.99 26.77 4.15 n/a 3.22

    S&P 500 0.10 6.02 30.69 2.94 n/a 4.05

    GMO Fixed Income Inception 2Q YTD YTD Value One Five Ten Since

    Strategies/Benchmarks Date Currency 2011 2011 Added Year Year Year InceptionGlobal Bond* 12/31/95 USD 3.15 4.86 0.97 14.16 5.63 7.60 6.29

    J.P. Morgan Global Gov't. Bond 3.33 3.89 10.15 7.62 8.01 5.96

    Emerging Country Debt* 4/30/94 USD 3.03 5.53 0.44 19.65 9.26 14.03 16.60

    J.P. Morgan EMBI Global + 4.03 5.09 11.73 9.59 10.21 11.92

    Emerging Country Local Debt Invst.** 2/29/08 USD 3.35 6.09 -0.86 20.72 n/a n/a 5.62

    J.P. Morgan GBI-EM Diversified 4.14 6.94 19.59 n/a n/a 9.42

  • 7/31/2019 2q 2011 European Update

    3/47

    GMO European Quarterly Update 3

    2011 Performance of GMO Strategies and Benchmarks

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction ofmanagement fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assumethe reinvestment of dividends and other income. A GIPS compliant presentation is available at www.gmo.com.

    Total Return Net of Fees Aver age Annual Total Retur n

    GMO Asset Allocation Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date Currency 2011 2011 Added Year Year Year Inception

    Global Balanced Asset Allocation 6/30/88 USD 2.22 5.00 0.96 19.80 5.58 8.07 10.14

    Blended Benchmark 0.98 4.04 20.59 4.58 4.90 8.32

    Real Return Global Balanced Asset Alloc. 6/30/04 USD 2.33 4.48 0.72 17.00 5.21 n/a 6.89Blended Benchmark 0.74 3.76 18.91 3.53 n/a 4.98

    Global Allocation Absolute Return 7/31/01 USD 1.59 3.03 -1.32 10.33 5.90 n/a 10.20

    CPI Plus 5% 1.59 4.35 8.56 7.18 n/a 7.50

    Global All Country Equity Allocation 12/31/93 USD 2.86 6.51 1.70 31.01 4.60 8.34 9.28

    Blended Benchmark 0.24 4.81 30.47 3.08 4.68 7.24

    Global Developed Equity Allocation 3/31/87 USD 3.21 6.84 1.55 30.79 3.14 7.62 9.41

    Blended Benchmark 0.47 5.29 30.52 2.28 3.92 7.13

    U.S. Equity Allocation 2/28/89 USD 3.16 7.36 1.13 28.65 2.59 3.28 10.18

    Blended Benchmark 0.02 6.22 31.81 3.23 3.11 9.55

    GMO Absolute Return Inception 2Q YTD YTD Value One Five Ten Since

    Strategies/Benchmarks Date Currency 2011 2011 Added Year Year Year InceptionAggr essive Long/Short 9/30/00 USD -0.71 1.80 1.74 7.07 1.30 2.73 5.85

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 1.87 2.01 2.25

    Tactical Opportunities 9/30/04 USD 8.15 1.86 1.80 -12.62 -5.27 n/a -8.13

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 1.87 n/a 2.22

    Emerging Country Debt Long/Short 3/31/96 USD 0.53 0.83 0.63 8.38 5.45 9.02 11.31

    J.P. Morgan U.S. 3 Month Cash 0.10 0.20 0.49 2.93 2.71 3.84

    Currency Hedge 7/31/03 USD 1.78 2.81 2.62 8.06 -1.07 n/a 0.72

    J.P. Morgan U.S. 3 Month Cash 0.10 0.20 0.49 2.93 n/a 2.83

    Fixed Income Hedge 8/31/05 USD -0.32 0.95 0.75 5.54 -6.60 n/a -4.73

    J.P. Morgan U.S. 3 Month Cash 0.10 0.20 0.49 2.93 n/a 3.15

    Emerging Currency Hedge 3/31/06 USD 1.23 5.84 5.64 16.01 6.11 n/a 5.17

    J.P. Morgan U.S. 3 Month Cash 0.10 0.20 0.49 2.93 n/a 3.03

    Mean Reversion 2/28/02 USD 0.08 1.21 1.15 -3.25 3.23 n/a 8.35

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 1.87 n/a 1.95

    Systematic Global Macro 3/31/02 USD 3.72 -0.27 -0.33 1.21 7.64 n/a 7.81

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 1.87 n/a 1.96

    Completion 8/31/07 USD -2.04 1.74 1.68 -4.39 n/a n/a 12.43

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 n/a n/a 0.92

    Multi-Strategy 10/31/02 USD 1.41 1.44 1.38 0.32 2.44 n/a 2.92

    Citigroup 3-Mo. T-Bill 0.02 0.06 0.14 1.87 n/a 1.97

  • 7/31/2019 2q 2011 European Update

    4/47

    4 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    European Market Review

    Global equity markets were buffeted throughout the

    quarter by a mixture of contradictory news. Steady

    growth in emerging markets and positive economic data

    from the U.S., Germany and France were helpful. In

    contrast, markets were depressed on news of the

    continuing problems in the Eurozone, rising inflationary

    pressures and an apparent slowdown in Chinas

    economy. Overall global equities ended the quarter

    slightly negative with the MSCI World Index showing a

    decline of 1.7% in euro terms.

    The best performing equity regions were in Europe

    with the European index returning 0.3%. The advance in

    Europe took place despite the debt crisis. Initially,

    attention was focused on Portugal but events quickly

    turned to Greece as the threat of default heightened, not

    helped by increasing levels of political and social turmoil.

    However, equity investors seemed to take comfort in the

    Greek parliament passing a crucial package of austerity

    measures.

    The Pacific ex-Japan and emerging equity markets

    vied to be the worst performing region, achieving

    respective returns of -2.4% and -3.1%. The U.S. equity

    market also fell with a -2.0% return in euro terms.

    Style factors had only minor impact on overall market

    performance this quarter. There was little appreciable

    difference in returns between large/medium and small

    capitalisation stocks in equity markets, although large

    growth companies were slightly ahead of traditional

    value.

    The Eurozone sovereign debt crisis saw investors

    seek out the safe havens of U.S. and German government

    debt. Global bonds and emerging market debt rose

    adding 1.1% and 1.8% respectively during the quarter,

    both in euro terms. EMU government bonds also gained

    slightly with the JPM EMU Government All Maturities

    Index returning 0.7%. The U.S. Dollar as well as the

    British Pound lost about 2% and the Japanese Yen was

    flat with +0.4% against the Euro.

    Mounting concern about the strength of the global

    recovery and an unexpected announcement in June by

    the International Energy Agency that it would release 60

    million barrels from its strategic oil reserves as a

    replacement for Libyan supply losses led to a fall of about

    10% in the oil price during the quarter.

    Asset Allocation

    Review

    Throughout the first four months of 2011, investors

    around the globe continued to climb a wall of worry, with

    their speculative zeal trumping any and all concerns

    surrounding a nasty brew of poor employment numbers,

    worsening housing markets, rising commodity prices, and

    dysfunctional European parliaments. And, lets not

    forget the rolling series of civil wars in the Middle East

    GMO Allocation

    Quality

    23.1%Alpha Only

    17.0%

    Cash &

    Equivalents

    2.1%

    Special

    Situations

    3.7%

    Asset

    Allocation Bond

    2.7%

    Emerging

    Country Debt

    0.5%

    Strategic

    Fixed Income

    10.7%

    Domestic

    Bond

    2.5%

    Emerging

    Markets

    12.1%

    Flexible

    Equities

    3.3%

    International

    Core Equity

    13.3%

    International

    Growth

    4.6%

    International

    Intrinsic Value

    4.6%

    Global Balanced Asset Allocation: One ExampleRecommendations as of June 30, 2011

    Benchmark: 65% MSCI ACWI Index /35% Barclays Capital Aggregate

    Note: Asset Allocation ranges are 20% for U.S. andinternational equities and -10%/+15% for fixed income.

    Benchmark

    Fixed

    Income

    35.0%

    Emerging

    Equities

    8.8%

    International

    Equities

    28.4%

    U.S.

    Equities

    27.8%

    GMO Active

    Weighting Decisions

    U.S.

    Equities

    -4.7%

    Int'l.

    Equities

    -2.6%

    Emerging

    Equities

    +3.3%

    Fixed

    Income

    +4.2%

    -10% -5% 0% 5% 10%

  • 7/31/2019 2q 2011 European Update

    5/47

    GMO European Quarterly Update 5

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    and North Africa and the nuclear crisis in Japan. In May,

    however, it was as if having reached the top of the wall

    investors finally took a more serious survey of the

    landscape and concluded all is not well. Perhaps it was

    the looming end of QE2 and all of the unknowns

    associated with it, or the realization that the Greek debt

    crisis was merely the tip of a liquidity and sovereign debt

    crisis iceberg that could destabilize European banks (and

    the entire money market system here in the U.S.).

    Whatever the tipping point, a healthy dose of fear, not

    panic, finally set in. Global equity markets trimmed

    about 210 basis points during May and almost another

    160 basis points in June. The rising yields in the bond

    market gave way to a classic flight to safety, and Treasury

    yields fell soundly to around 3.0% in the latter part of the

    quarter. Our view is that this correction, while painful, is

    likely not over, with equity markets around the planet

    trading well above their fair value. As always, the path,

    speed, and timing of the movement to fair value is

    unknowable, but whether its a pin-prick event or a slow

    grind, we believe a hunker down mentality is prudent

    when it comes to portfolio positioning.

    Strategies

    There is, of course, no law that forbids expensiveasset classes from becoming more expensive. There are

    no chiseled tablets forbidding historically low bond yields

    from going lower. And some bold and courageous

    investors may want to stay for additional courses. Wall

    Street is more than willing to provide the investment

    rationale for such a decision, and CNBC can no doubt

    line up a healthy roster of yea-sayers to serve up the next

    dish. But we have other plans. We remain defensive.

    We remain cautious. We are cognizant that, while

    valuations are not nearly as stretched as we saw in thesummer of 2007, they dance dangerously close. That

    while the high yield market one of the many canaries in

    the coal mine is signaling all sorts of speculative froth

    (from historically low spreads and all manner of dodgy

    conditions), it is not as bad as it was only four years ago.

    Faint praise indeed. And lets not get started again on

    Treasuries and their negative yields. No, there are still

    plenty of investors willing to stay at the speculative feast,

    but we have pushed ourselves away from the table.

    Our broad strategies are:

    Emphasize Quality stocks. While one month doth

    not a trend make, Mays substantial market pull-back

    was illustrative of what we expect to be a string of

    market movements over the coming year. The market

    witnessed a wake-up call, if you will, to the worrisome

    sets of crises globally. The laundry list of worries

    the looming end of QE2 most notably has been

    known for some time, yet the urgency of them

    somehow spooked the markets starting in May. With

    that, we witnessed a sizable rotation into Quality. Our

    Quality Strategy outperformed the S&P 500 by over

    330 basis points, as the appeal of highly profitable and

    stable, unlevered business models suddenly trumped

    animal spirits. We dont believe this rotation is

    anywhere near complete. Nor do we believe that the

    list of worries is by any means checked off. Far

    from it. Therefore, we happily maintain our Quality

    bias.

    Maintain exposure to emerging markets, but with

    some precise hedging. We remain overweight

    emerging markets within global equity mandates as

    they represent a sub-asset class priced to deliver very

    decent returns. However, the China real estate

    bubble remains on our watch list, and, where

    appropriate, we have taken pains to surgically hedge

    specific areas of the global market that are highly tied

    to continued growth in Chinese real estate.

    Specifically, we have hedged direct exposure

    Chinese real estate developers and banks but wehave crafted a custom basket of secondary and tertiary

    plays on the China bubble days coming to an end (e.g.,

    Australian copper miners and luxury goods

    manufacturers). Either way, our position remains

    constructive on the broad universe of emerging

    equities, but with some serious caveats regarding

    China.

  • 7/31/2019 2q 2011 European Update

    6/47

    6 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    Bonds back into very, very expensive territory.

    The rally in bonds this quarter can be called many

    things: a flight to safety, a deflation play, etc. We call

    it the way we see it: already expensive bonds just

    became more expensive. Our sober forecast for

    bonds is global in nature, just from a pure valuation

    perspective. Throw in a good dose of sovereign credit

    worries and the end of QE2, and you have a whole

    basket of excuses to, where possible, avoid bonds.

    Maintain positions in low duration fixed income

    and cash/cash plus in balanced portfolios.

    Truth be told, we dont necessarily like holding these

    low-duration cash instruments given their low yields.

    Their appeal, then, is not so much that theyre going

    to make us a ton of money, but rather that they can

    act as dry powder that we can deploy when

    expensive assets elsewhere (read: stocks and

    bonds) get closer to fair value. Yes, these holding

    are a short-term drag on performance, but the

    option they provide to put cash to work at better

    pricing gives us some degree of comfort.

    Invest in conservative absolute return strategies,

    where available. Ideally, absolute return strategies

    are often a pure play on manager skill. Therefore, the

    return streams should have little correlation to the

    movements of the markets. Such investment

    instruments can provide equity-like returns, while

    helping to diversify other parts of ones portfolio.

    Performance Review and Outlook

    U.S. Equities

    Market Review

    In the second quarter of 2011, U.S. investors softenedtheir affinity for the riskiest segments of the market, as

    developments domestic and abroad called into question

    the sustainability of U.S. stocks year-long run. European

    sovereign debt woes, and their potential to destabilize a

    global economic recovery, continued to weigh on global

    markets during the period as troubles in Greece were

    viewed as a potential canary in the proverbial coal mine

    for indebted nations around the globe. While U.S. stocks

    had in recent quarters resisted falling prey to European

    gloom, the second quarter combination of continued

    European troubles with a number of stumbling points in

    the U.S. economic recovery held stocks in check. The

    S&P 500 started off the quarter with a strong April

    return, but spent the remaining two months giving back

    those gains to finish with a modest +0.1% quarterly

    return.

    Where European troubles highlighted a more

    generalized risk for U.S. investors that European

    sovereign debt problems could spill over into U.S.

    markets domestic economic data during the quarter

    highlighted a more specific risk for U.S. investors: that a

    stalled U.S. economic recovery would put a limit on stock

    returns. During the quarter, U.S. investors fretted over a

    variety of economic reports showing slowing or stalling

    in the pace of the economic recovery. From jobs data to

    manufacturing reports, a slew of widely reviewed

    economic indicators conspired to tell a not so fast

    cautionary tale to U.S. investors bidding up stocks in

    anticipation of a return to pre-recession economic

    conditions. Hints of a less-than-stellar economic

    rebound were particularly troubling for stocks and areas

    of the market perceived most levered to general

    economic conditions. Indeed, the S&P 500s modest

    +0.1% quarterly return belied a significant underlying

    split in returns to risk-taking within equities. Of the 10

    GICS economic sectors within the S&P 500, only five

    posted positive absolute returns during the quarter, with

    U.S. Equity MarketsSecond Quarter 2011 Performance

    0.1%

    -0.5%

    0.8%

    -1.5%

    0.4%

    3.6%

    0.0%

    -3%

    -2%

    -1%

    0%

    1%

    2%

    3%

    4%

    5%

    Russell 2500S&P

    500

    Dow

    Jones

    U.S. TSMGrowth

    MSCI

    U.S.

    REITValueGrowth

    Russell 1000

    Value

  • 7/31/2019 2q 2011 European Update

    7/47

    GMO European Quarterly Update 7

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    U.S. EquitiesRelative Performance of Selected Groups versus the S&P 500

    Year-to-Date June 30, 2011

    Size

    InvestmentDisciplin

    es

    Se

    ctors

    Financials

    -10.0

    -8.0

    -6.0

    -4.0

    -2.0

    0.0

    2.0

    4.0

    12/10 2/11 4/11 6

    Consumer Discretionary

    -4.0

    -3.0

    -2.0

    -1.0

    0.0

    1.0

    2.0

    3.0

    12/10 2/11 4/11 6/11

    Information Technology

    -6.0

    -4.0

    -2.0

    0.0

    2.0

    4.0

    12/10 2/11 4/11 6/11

    Russell 2000

    -4.0

    -3.0

    -2.0

    -1.0

    0.0

    1.0

    2.0

    3.0

    12/10 2/11 4/11 6

    Energy

    -2.0

    0.0

    2.0

    4.0

    6.0

    8.0

    10.0

    12.0

    12/10 2/11 4/11 6/

    Largest 100

    -2.0

    0.0

    2.0

    4.0

    6.0

    8.0

    12/10 2/11 4/11 6/11

    Cheap on Price/Intrinsic Value

    0.0

    2.0

    4.0

    6.0

    8.0

    10.0

    12/10 2/11 4/11 6/11

    High Price Momentum

    -2.0

    0.0

    2.0

    4.0

    6.0

    8.0

    10.0

    12/10 2/11 4/11 6

  • 7/31/2019 2q 2011 European Update

    8/47

    8 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    the best performance coming from more defensive areas

    of the market. Health Care led sector winners, rising

    7.8%. Utilities advanced 6.1%, and Consumer Staples

    gained 5.2%. On the negative side, more economically-

    exposed sectors posted negative returns during the

    period, with Financials (-6.0%) and Energy (-4.7%)

    leading the decliners. The split in returns to risky areas of

    the market could also be seen in the returns to a number

    of investment factors during the period. High quality and

    low volatility stocks posted strong relative returns, while

    their low quality and high volatility counterparts lagged

    the market by similar margins. Momentum metrics also

    underperformed during the quarter, hurt by their

    exposure to the economically exposed areas of the

    market that had performed well recently. Bottom-up

    valuation metrics delivered mixed relative returns, with

    those incorporating company quality in their valuation

    faring the best. Investors distaste for risk was also

    exhibited in index returns for the quarter, with large cap

    stocks outperforming mid and small caps.

    Outlook

    In the long run, investment returns have three

    sources: dividends, fundamental growth, and changes in

    price multiple. There are innumerable factors thatinfluence a companys ability to pay dividends and grow,

    and the multiple the market is willing to pay for it. But at

    the heart of a value investment philosophy is an

    understanding of what is knowable, what is unknowable,

    the risks to both the known and unknown, and where we

    derive an edge. Our focus remains on understanding the

    knowable, acknowledging the unknown, weighing the

    associated risks, and finding investments trading for less

    than theyre worth.

    International Equities

    Market Review

    The sovereign debt crisis in Europe was the dominant

    news story affecting developed international equity

    markets. The received wisdom (reflected in bond and

    CDS prices, if not on the balance sheets of banks) is that

    Greece will eventually default or restructure. But there is

    also a widespread view that, to repeat what has become a

    very tired metaphor, the can will be kicked down the road

    for several years. And if this happens with the European

    taxpayer ultimately bearing much of the burden, the crisis

    need not be disastrous for equity markets broadly. The

    can kicking at the end of the quarter allowed the MSCI

    Europe index to end the period above water, returning

    +2.4% for the period in U.S. dollar terms. The broader

    MSCI EAFE index of developed international stocks

    returned +1.6%.

    In Europe (and elsewhere) the more defensive

    Pharmaceuticals and Consumer Staples sectors, as well as

    automotive and retail stocks, drove the outperformance.

    Large pharma stocks like Novartis, Roche, Sanofi, and

    GlaxoSmithKline enjoyed gains ranging from 10% to

    20%. Although Financials and many riskier industries

    underperformed, there appeared to be a fairly strong

    appetite for equities, perhaps stimulated by relatively

    derisory bond yields.

    Greece was the worst performing developed market

    for the quarter, with the MSCI Greece index falling 18%

    in local terms. It was not a complete wipeout for the

    PIIGS though, as Ireland was at the other extreme,

    gaining 5.3%. Germany was the best performing major

    market, up 4.0% in local terms. While Italy had shown

    some signs of graduating from the PIIGS acronym

    (shortened by many commentators to PIGS), that

    owner of the second I suffered a whiff of contagion,

    International Equity MarketsSecond Quarter 2011 Performance

    -2.4%-2.9%

    0.2%

    -0.8%

    0.2%

    2.4%

    1.6%

    -1.0%

    -0.2%

    -4%

    -2%

    0%

    2%

    4%

    In Local Terms

    In Dollars

    EAFE Europe

    S&P/IFC

    Compos

    (Emergin

    MSCI

    Pacific

    ex-Japan

    Japan

  • 7/31/2019 2q 2011 European Update

    9/47

    GMO European Quarterly Update 9

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    with a downgrade of its credit ranking, political concerns,

    and capital raising by a number of its banks, and the

    MSCI Italy index fell 4.7% in euro terms.

    Japan is showing some signs of recovery from the

    tsunami. The MSCI Japan index was up a meager 0.2%

    for the quarter in dollar terms. Consumer-oriented

    stocks and financials held up relatively well, but

    commodity dependent companies and utilities with

    nuclear power exposure suffered.

    While currency moves were not dramatic, a falling

    dollar contributed to positive returns and the

    outperformance of international equities. The MSCI

    EAFE index actually fell 0.8% when measured in local

    currencies. The Swiss franc and New Zealand dollar

    were the stronger performers, up over 8% against the

    U.S. dollar. The yen and euro both gained about 2.5%,

    while British sterling was virtually flat.

    Oil prices declined in May and June, falling about

    10% for the quarter, depending on the benchmark.

    Energy stocks were the worst performing global sector,

    though the price falls were muted. Broader commodity

    indices suffered their first quarterly declines since the end

    of the financial crisis, and the Materials sector also lagged.

    Large miners like BHP and Anglo American suffered

    modest declines, and Glencores IPO in May came off

    with only muted success.

    Higher quality stocks outperformed during much of

    the quarter. On GMOs measure blending high and

    stable profitability with low leverage, the highest quartile

    of the EAFE markets outperformed by nearly 4%.

    Understandably, the gap was widest in Europe, but was

    observable in Japan as well. Defensive industries (onGMOs definition) outperformed by a similar margin.

    Lower price volatility stocks also did well and, indeed, the

    low earnings volatility component of GMOs quality

    measure was more significant than high profitability or

    leverage (though all three were ahead).

    Growth outperformed Value for the quarter, as

    defined either by MSCI indices or price/book (though

    not as defined by analyst consensus forecasts). MSCI

    EAFE Growth gained 2.1%, while MSCI EAFE Value

    was up 1.0%. Smaller cap stocks are generally more

    cyclical, and the MSCI EAFE Small Cap index rose a

    more modest 0.8%

    Outlook

    The more the pendulum swings from greed toward

    fear, the more opportunities there will be for an investor

    in equity markets. While it would be nice to be able to

    say things have gone so far as to provide mouthwatering

    valuations at little downside risk, things are not generally

    so simple. The good news is that the story of the lack ofgrowth in much of the developed world has become so

    widespread that virtually none is priced in for many

    companies that have stellar track records, and so the odds

    seem in the investors favor. Some of the more

    distressed parts of the world have fallen severely, and

    may rebound sharply, but investing there requires

    something of a gambling mentality. And stocks with

    clear exposure to growth, most likely from China, tend to

    be at least fully priced. Still, volatility and fear are friends

    of prudent investors, so, while the markets in aggregatemay not present the valuations we would hope for, there

    are opportunities within them that excite us.

    Emerging Market Equities

    Market Review

    Emerging markets suffered minor losses over the

    second quarter, with a strong April getting pulled down

    by weak May and June returns. Investors spent the

    quarter chewing over the myriad developments in the

    sovereign debt crisis and the pace of monetary tightening

    in several key markets. The last days of the quarter saw

    sentiment turn bullish as concern of a Greek default

    eased after the government secured enough votes to push

  • 7/31/2019 2q 2011 European Update

    10/47

    10 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    ahead with budget cuts. The quarter saw country

    performances as diverse as an 8.5% jump in Chile and a

    15.2% plunge in Peru. Among sectors, the spread was

    tighter, with Consumer Discretionary leaping 8.3% and

    Energy dropping 7.4%.

    Russian Energy underperformed the asset class as the

    outlook for commodities grew less rosy and concern

    deepened that tighter monetary policy in Russia would

    curb economic growth. The central bank unexpectedly

    raised interest rates in April to check inflation. The

    central bank had in the past relied on currency gains and

    higher reserve requirements as its tools in fighting

    inflation rather than hiking rates. The concerns over the

    ultimate resolution to Greeces debt crisis, inflation

    fighting efforts in countries such as China and India, and

    speculation that U.S. demand may be slowing have all led

    to a fall in energy prices.

    Investors in Hungary were cheered by signs of a

    strengthening global economic recovery. Closer to

    home, they found comfort in the ongoing talks between

    the government and commercial banks on ending a

    moratorium on evictions and stimulating mortgage

    lending. The market was also influenced by rumors that

    the government would lower a special tax on banks as

    part of an agreement with lenders to help distressed

    borrowers after the moratorium on evictions runs out.

    The government had relied on temporary industry taxes

    and the effective nationalization of private pension

    portfolios to reach budget targets in the past rather than

    imposing austerity measures directly on the populace.

    A happy combination of rapid growth, slowing

    inflation, and low interest rates is boosting domestic

    spending in Indonesia. The central bank forecasts the

    economy to grow as much as 6.5% this year, the fastest

    pace since 2004. However, inflation decelerated, with

    consumer prices rising 6.0% in May from a year earlier.

    This has helped convince the central bank to let the

    benchmark interest rate stay at a near record low of

    6.75%.

    Perus stocks dropped as the market awaited President

    -elect Humalas economic policies. Investors fear that he

    will expand the role of the state and call for higher

    mining taxes. Humala said that he is seeking economic

    growth with social inclusion. Some of the gloom was

    lifted by the central bank unexpectedly keeping its

    benchmark rate unchanged for the first time in six

    months.

    Outlook

    This outlook takes a look at some recent significant

    political developments in emerging markets. Changes in

    leadership in these markets often have a greater impact

    on the macroeconomic policies of a country than they do

    in developed markets.

    Peru Elections

    President-elect Humala has put investors on edge by

    some of his campaign pledges to revise mining contracts

    and revisit free-trade agreements with the U.S. and other

    nations. Peru is the worlds largest silver and third largest

    copper producer. The central bank estimates that mining

    projects will account for almost half of the $47.5 billion

    of private investment expected in Peru from 2011 to2013. While he has praised his one-time ally, Venezuelan

    President Hugo Chavez, in the past, more recently his

    comments have been peppered with references to the

    business-friendly policies of Brazil. In a trip to the U.S.

    after his election, he stated that relations are good, but,

    We want to improve them during my government. His

    post-election comments have also included a goal of

    balancing economic growth with social inclusion.

    Investors, however, remain uncertain of his policies and

    eagerly await his first moves once he takes office at theend of July.

  • 7/31/2019 2q 2011 European Update

    11/47

    GMO European Quarterly Update 11

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    Thailand Elections

    The Pheu Thai party, backed by former premier

    Thaksin Shinawatra, won 265 seats in the 500-member

    parliament. Yingluck Shinawatra, Thaksins youngest

    sister, will become prime minister, and has built a five-

    party coalition to broaden her mandate. Thaksin was

    ousted in a 2006 coup and has lived overseas since fleeing

    a jail sentence for abuse of power. Parties linked to him

    have won the past four national elections based on

    support in northern rural areas for cheap health care

    plans and microcredit policies. While the waters could

    yet get muddy, there is a sense that this time Pheu Thai

    can corral more support than earlier. A reduction in

    political uncertainty would cheer businesses and improve

    growth prospects. The party made campaign pledges to

    raise the minimum wage and guarantee rice prices for

    farmers. Optimists hope for greater political stability and

    controlled fiscal expenditure while pessimists fear a

    return to political disorder and patronage spending.

    Elections in the Middle East

    Massive street protests forced Egyptian President

    Mubarak to resign in February and cede interim authority

    to the Supreme Council of the Armed Forces. But, five

    months later, there is still considerable opacity over the

    future political landscape. Parliamentary elections are

    scheduled in September. Egypts Cabinet approved a

    draft law under which half of the seats would be

    contested through slates of candidates and the rest by

    individual candidates. According to the draft, parliament

    would have 500 seats and candidates of different parties

    may run on one slate, allowing alliances to be struck.

    Mubaraks 30-year-long stay in office has shrunk any

    opposition, leading to a dearth of viable alternative

    parties. The Egyptian Brotherhood is one of the few

    groups with a significant grassroots network. Senior

    officials at the Brotherhood pledge support for private

    enterprise and free markets. However, there is

    skepticism as to whether they will be a force for

    moderation or a divisive, fundamentalist element.

    Protests, though on a much smaller scale, are ongoing in

    Egypt as activists demand more rapid trials of former

    government officials and policemen accused of killing

    protesters in the uprising that toppled Mubarak.

    In Morocco, the other emerging market in the Middle

    East, a draft constitution was widely approved in a

    referendum. The constitution was written at King

    Mohammeds orders in response to protests that echoed

    the uprisings in Tunisia and Egypt. Under the plan, the

    prime minister will be chosen from the party that wins

    elections and will replace the king as the head of

    government. However, the king will retain the power to

    overrule or dismiss parliament. While many supported it

    as a significant step toward democratization, others felt

    that it wasnt close enough to their ideal. Moroccos

    tradition of greater social freedoms and deeper political

    participation suggest that this move, while well short of

    achieving genuine democracy, will probably be enough to

    deflect the current pressure.

    Fixed Income

    Review

    Bonds had a good quarter, particularly unhedged

    foreign bonds, as yields fell nearly everywhere and the

    U.S. dollar declined. U.S. Treasuries returned +2.5%,

    slightly outpacing the broader Barclays U.S. Aggregate

    Bond index, where widening sector spreads detracted.

    USD emerging debt (EMBIG series) returned +4.0%,

    partially a reflection of the relatively longer interest-rate

    duration of the asset class, but also due to the spread

    return from it. Foreign government bonds, both from

    developed countries and emerging countries, produced

    positive returns, all the more so when the positive

    currency returns were added given the U.S. dollars near

    uniform decline.

  • 7/31/2019 2q 2011 European Update

    12/47

    12 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    The main exception to this positive bond story

    continued to be the fallen angels of sovereign bonds,

    less charitably referred to as PIG (Portugal, Ireland,

    Greece). Lucky for J.P. Morgans series, none of these

    countries pertains to its Global Government Bond

    Index series, which draws the line to include Italy and

    Spain but not the PIGs. Unlucky for the fallen angels,

    unless they default, they are ineligible for J.P. Morgans

    Emerging bond indices, which exclude high income

    countries unless they default. So, the fallen angels, all

    at or near junk ratings at quarter end, are homeless from

    a bond index perspective, compounding woes for the

    countries in their search for buyers of their debt.

    In terms of yield levels, interest rates fell in most

    markets. Among developed countries, Canadian,

    Swedish, and U.S. yields fell the most, and Japanese and

    New Zealand the least, with the eclines ranging from 10-

    30 basis points for 10-year yields. Among emerging

    countries, the declines were greater than 30 basis points

    in eight markets, although here we take 5-year yields.

    Only in Turkey did rates rise and do so sharply, as the

    market lost patience with the Central Bank of Turkeys

    monetary policy experimentalism.

    In currencies, apart from idiosyncratic circumstances,

    the foreign currencies gained relative to the U.S. dollar

    fairly broadly for a second quarter in a row. Most

    emerging currencies rose relative to the U.S. dollar, with

    the largest quarterly spot gain coming from Colombian

    peso, +5.8%. Another nine currencies registered spot

    gains greater than 2%, including Brazil, Poland, Czech

    Republic, Korea, Singapore, Taiwan, Chile, Hungary, and

    Israel.

    On the downside, Turkish lira was the stand-out loser,

    -4.9%. A yawning current account deficit (financed

    mostly by short-term debt) defied authorities confidence

    that their unusual monetary policy would

    simultaneously cool domestic demand and deter hot

    money inflows. The CBRT did acknowledge in its spring

    financial stability report that sharply rising short-term

    borrowing (mostly by banks) was the main threat to

    financial stability. They vowed to continue reserve

    requirement hikes (rather than interest-rate hikes) to

    pinch credit growth.

    Other laggards included Argentine peso, -1.4%, and

    Thai baht, -1.3%. In Argentina, although the question of

    whether Cristina Fernandez de Kirchner would run for

    president in the fall was settled (yes), locals were already

    voting with their pesos in leaving the country. Although

    difficult to observe directly, the parallel (or ironically

    named Blue Chip) peso rate fell even faster than the

    official one. Despite the declines, the official pesos

    return was +0.5% due to the high carry in the NDF (non

    -deliverable forwards) points. In Thailand, pre-election

    Source: J.P. Morgan

    European Government Bond

    Total Returns 2Q vs. 1Q 2011

    -2.4%

    0.2%

    -8.6%

    -5.7%

    2.1%

    0.5%

    -0.4%

    -2.0%-2.3%

    -14.5%

    -11.8%

    -6.0%

    0.5%1.0%1.4%1.9%1.9%2.1%

    Germ

    any

    Fran

    ce

    Netherlan

    ds

    Belgi

    um Italy

    Spain

    Irelan

    d

    Portu

    gal

    Gree

    ce

    1Q 2011

    2Q 2011

    Total Returns Second Quarter 2011

    2.3%

    4.0%

    1.6%

    3.1%

    2.2%

    1.1%

    2.5%

    0.0%

    0.5%

    1.0%

    1.5%2.0%

    2.5%

    3.0%

    3.5%

    4.0%

    4.5%

    U.S. Gov't.

    Bonds

    (JPM GBI)

    USD

    Bonds

    (Barclays

    U.S. Agg)

    USD

    Emerging

    Bonds

    (EMBIG)

    Non-U.S.

    Bonds:

    Developed

    (JPM GBI)

    Non-U.S.

    Bonds:

    Emerging

    (JPM GBI-

    EM)

    Currency

    Bonds

  • 7/31/2019 2q 2011 European Update

    13/47

    GMO European Quarterly Update 13

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    jitters weighed on the baht and temporarily narrowed

    onshore-offshore forwards.

    In Peru, leftist candidate Ollanta Humala emerged

    victorious, although the margin was small. During the

    final months of the campaign he did a Lula makeover,

    and each gesture lifted the depreciation pressure on the

    new sol. By quarter end, the new sol had risen by 1.9%, a

    middling performance in the region (Chile +2.2%, Brazil

    +4.4%, Mexico +1.5%).

    Chinas currency ended the quarter +1.3%, with all of

    the gains coming in April, ahead of the U.S./China

    Strategic and Economic dialog. As has become a

    seasonal pattern, China allows the currency to rise ahead

    of the meeting (and the U.S. semiannual report on

    currency manipulation), then backs off afterwards.

    In G10, somewhat unusually, the quarters lead

    gainers were safe haven Swiss franc, +8.7%, and high-

    carry New Zealand dollar, +8.3%. Swiss franc reached all

    -time highs in real effective terms, prompting one Swiss

    lawmaker to suggest imposing negative interest rates on

    foreign investors (read: Greek deposit flight) to deter

    further inflows. New Zealand dollar, meanwhile,

    continued to benefit from post-quake reconstruction and

    insurance inflows.

    The euro ended the quarter surprisingly well,

    considering that euro member Greeces bonds are pricing

    significant bondholder losses. The single currency see-

    sawed between 1.405 and 1.475 relative to the dollar

    during the quarter, alternatively buoyed by the ECBs first

    post-crisis interest-rate increase (and the strong hints of

    more) and deflated by the ongoing slow-motion

    sovereign crises in the periphery. During the quarter, the

    ratings for Greek debt were cut deep into junk; Portugal

    rested on the edge of junk (and downgraded to below

    right after quarter end); while Ireland delivered a rather

    nasty haircut to bank bondholders.

    In credit markets, emerging debt spreads (EMBIG

    series) tightened by 10 basis points to 288 basis points

    during the quarter. Eurozone countries suffered more

    downgrades from the ratings agencies, which were not

    convinced by plans to allow Greece to impose losses on

    bondholders without technically defaulting. CDS spreads

    on Greece more than doubled to imminent-default levels

    in line with the CCC/Caa1 ratings. Ireland and Portugal

    kept their investment-grade ratings through the end of

    the quarter, although Moodys dropped Portugal to Ba2

    immediately afterwards. Liquidity in the emerging cash

    bond market deteriorated slightly and the average bid-

    offer spread widened to 67 basis points at the end of the

    quarter from 62 at the beginning. New issuance of $81

    billion fell slightly from the first quarter, but was above

    the average of the previous four quarters.

    The biggest index gainers were Ivory Coast (+12.5%),

    Nigeria (+6.9%), Venezuela (+6.4%), and Uruguay

    (+6.4%). The Ivory Coast bond continued to rally during

    the quarter as the internationally-recognized Ouattara

    administration took office, although it missed another

    Second Quarter 2011 Change in Interest Rates (10Y DM, 5Y EM)

    0.4

    0.00.0-0.1-0.1-0.1-0.1-0.2-0.3-0.3-0.3

    -0.4-0.4-0.4-0.4-0.5-0.5

    -0.7

    -0.9

    -0.3-0.3-0.3-0.3-0.3-0.2-0.2

    -0.2-0.2-0.1-0.1

    New

    Zea

    land

    Japa

    nG

    BI

    Eur

    o

    Aus

    tralia

    Sw

    itzerla

    nd UK

    Nor

    way

    U.S

    .

    Sw

    eden

    Can

    ada

    Indo

    nesi

    a

    Mex

    ico

    Hon

    gK

    ong

    Rus

    sia

    Bra

    zil

    Pol

    and

    S.A

    frica

    Cze

    ch.R

    ep.

    Sin

    g.

    Isra

    el

    Chi

    le

    Kor

    ea

    Hun

    gary

    Taiw

    an

    GB

    I-E

    MD

    Mal

    aysi

    a

    Thaila

    nd

    Chi

    na

    Turk

    ey

    Source: J.P. Morgan

  • 7/31/2019 2q 2011 European Update

    14/47

    14 GMO European Quarterly Update

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    coupon without committing to a schedule for making up

    the overdue payments. Nigerian elections were peaceful

    by local standards and the re-elected president showed

    signs of supporting positive reforms in the electricity

    sector. Venezuelan bonds recovered from earlier losses

    at the end of June when President Chavez had to be

    hospitalized in Cuba and was found to have cancer. The

    Uruguayan economy performed well in the first quarter,

    and the Central Bank conducted a well-received investor

    road show.

    Index laggers for the quarter included Belize (-19.9%),

    Iraq (-0.2%), Pakistan (+0.2%), and Serbia (+1.4%). The

    Belize bond collapsed at the end of June when the

    government nationalized the electric utility, which was

    not able to pay for imported fuel. Iraq and Pakistan both

    experienced political conflict well-covered by the media.

    In asset-backeds, the market generally experienced

    tightening spreads. According to J.P. Morgan, credit card

    spreads declined from 22 basis points to 16 basis points,

    auto spreads from 40 basis points to 32 basis points, and

    student loan spreads remained flat at 40 basis points.

    The ABX subprime indices declined sharply quarter-over

    -quarter, although the final week of June did show

    improvement. For the quarter, the triple-A Indices were

    4% to 14% down in price; however, they finished the

    quarter 2% to 10% off of their lows.

    Strategies

    Fixed income strategies were mixed during the

    quarter: currency positioning, both developed and

    emerging, performed well, while developed markets

    interest-rate selection, emerging debt exposure, and asset-

    backed portfolios formerly used as cash sweep suffered

    during the quarter.

    The U.S. dollars somewhat uniform fall helped our

    long FX positions in both developed and emerging

    currencies. Overweights in New Zealand, Australia, and

    Norway contributed on the developed side, while

    overweight positions in Brazil, Hungary, Poland, Peru,

    Mexico, Chile, and Indonesia were notable in emerging

    fx.

    In developed markets interest-rate strategies,

    opportunistic positions hindered performance during the

    quarter, while the cross-market strategy and yield curve

    trades contributed positively. This quarter marks the

    culmination of a months-long research effort to refine

    Fixed Incomes systematic strategies. The group

    reconsidered all components of the strategies, including

    the base factors used, their weightings, and the

    construction of the ultimate target portfolios. The end

    result is a series of refinements, which the team believes

    will benefit going forward.

    Source: J.P. Morgan

    Second Quarter 2011 Currency Spot Returns

    5.84.4

    3.43.12.82.72.42.22.22.11.91.81.51.51.31.10.30.20.0-0.1

    -0.2-0.3-0.5-1.3-1.4

    -4.9

    8.78.3

    3.53.12.62.22.20.80.20.0

    Sw

    eden U

    K

    Can

    ada

    Eur

    o

    GB

    Iex-

    U.S

    .

    Japa

    n

    Nor

    way

    Aus

    tralia

    New

    Zea

    land

    Sw

    itzerla

    nd

    Turk

    ey

    Arg

    entin

    a

    Thaila

    nd

    Rom

    ania

    S.Afri

    ca

    Indi

    a

    Egy

    pt

    Hon

    gK

    ong

    Phi

    lippi

    nes

    Mal

    aysi

    a

    GB

    I-E

    MD

    Chi

    na

    Mex

    ico

    Indo

    nesi

    a

    Rus

    sia

    Per

    u

    Isra

    el

    Hun

    gary

    Chi

    le

    Taiw

    an

    Sin

    gapo

    re

    Kor

    ea

    Cze

    ch.R

    ep.

    Pol

    and

    Bra

    zil

    Col

    ombi

    a

  • 7/31/2019 2q 2011 European Update

    15/47

    GMO European Quarterly Update 15

    Please be advised, unless otherwise noted, all returns are in U.S. dollar terms.

    In external emerging debt strategies, country selection

    and security selection were detractors. Emerging local

    debt strategies benefited from instrument selection and

    country selection, but currency selection detracted.

    Finally, after nine consecutive quarters of positive

    contributions, the collateral pools reported negative

    returns for the quarter, detracting alpha from all of the

    strategies in direct proportion to each strategys exposure.

    Outlook

    At press time, no durable solution had been proposed

    to either deal with the PIGs issues or contain the fallout

    from not doing so. We put it in the too hard category

    to offer a credible opinion about the outcome (other than

    to say, having lived through a number of such crises inemerging countries, that default isnt the end of the

    world). Given the number of stakeholders and the

    chasm that separates their interests, a disorderly outcome

    cant be ruled out.

    On the matter of the U.S. debt ceiling, the

    irresponsible brinksmanship being played out by

    politicians and pundits in the news masks the more

    fundamental truth about the looming August deadline:

    the U.S. has both the willingness and ability to pay itsdebts in nominal U.S. dollars. Whether these dollars will

    be worth anything is a different question, one the market

    seems to be betting negatively about given the dollars

    near uniform decline.

    We continue to keep our portfolios tilted toward

    those currencies, interest-rate, credit markets, and

    instruments that we believe represent good value. At

    quarter end that included a continued underweight in the

    U.S. dollar, both against most G10 currencies and most

    emerging ones. In developed rates, we moved to

    overweight duration from underweight, mostly by cutting

    our substantial Japan underweight and adding a bit to our

    U.S. overweight. In credit, we still see value in asset-

    backed securities and emerging debt.

    Second Quarter 2011 J.P. Morgan EMBIG Returns by Country

    12.5

    6.96.46.46.25.55.55.45.3 5.45.14.74.74.64.4 4.54.1 4.34.14.0 4.04.03.73.73.63.43.12.92.82.42.1 2.42.01.91.91.91.81.6 1.71.40.2

    -1.3-0.2

    -19.4

    Beliz

    e

    Sen

    egal

    Iraq

    Pak

    ista

    n

    Serbi

    a

    Gab

    on

    Vie

    tnam

    Ukr

    aine

    Mal

    aysi

    a

    Arg

    entin

    a

    Gha

    na

    Chi

    le

    Bul

    garia

    Kaz

    akhs

    tan

    Rus

    sia

    Chi

    na

    Leba

    non

    Pol

    and

    Sri

    Lank

    a

    Turk

    ey

    Sou

    thAfri

    ca

    Dom

    .Rep

    .

    Geo

    rgia

    Per

    u

    EM

    BIG

    Cro

    atia

    Bel

    arus

    Cro

    atia

    Jam

    aica

    ElS

    alva

    dor

    Mex

    ico

    Phi

    lippi

    nes

    Hun

    gary

    Indo

    nesi

    a

    Bra

    zil

    Jord

    an

    Ecu

    ador

    Col

    ombi

    a

    Pan

    ama

    Egy

    pt

    Uru

    guay

    Ven

    ezue

    la

    Nig

    eria

    Ivor

    yC

    oast

    Disclaimer: The views expressed herein are through the period ending June 30, 2011, and are subject to change at any time based on market and otherconditions. This is not an offer or solicitation for the purchase or sale of any security, is not intended to be investment advice and should notbe construed as such. References to specific securities and issuers are for illustrative purposes only and are not intended to be, and should not beinterpreted as, recommendations to purchase or sell such securities.

  • 7/31/2019 2q 2011 European Update

    16/47

    16 GMO European Quarterly Update

    As of June 30, 2011

    GMO 2011

    GMO Global Equity StrategyInception: 7/31/96; Benchmark: MSCI World Index

    Performance (USD)1 Top Ten Holdings2,5

    Risk Profile Since 7/31/964

    Quarterly Strategy Attribution

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3 The MSCI World Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of global developed

    markets. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liabilityhereunder.

    4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk. Risk profile data is gross.

    5 The above information is based on a representative account selected because it has the least number of restrictions and best represents the implementation of the strategy.The performance information above is supplemental to the GIPS compliant presentation that was made available on GMOs website in April of 2011.

    Sector Weights5

    GICS Sectors

    Regional Weights5

    Characteristics5

    Global equity markets fell during most of the quarter but a rally in the last few days meant that the MSCI World Index eked out a gain of 0.5% when measured in terms of the weak US dollar,but provided negative returns from the perspective of most other currencies. The Global Equity Strategy outperformed its benchmark this quarter by 1.4%.

    The crisis in Europe continues its steady trundle towards an end game. The cost of borrowing in peripheral Europe reached ever higher during the quarter with market participants now pricingsome sort of restructuring of government debt in Greece as a certainty and in Portugal and Ireland as a near certainty. As policy makers vacillate, the bond markets have come to their ownconclusions.

    Nevertheless, European equities were the best performing developed market region, despite weakness in financials-dominated Greece and debt-laden Italy. European equities are pricing in adecent amount of disaster already; at the end of June, eurozone markets comprised 11 of the cheapest 13 developed markets, with discounts ranging from 12% for Germany through to 60% forGreece. By contrast, Canada trades at a premium, with little or no cushion for the unexpected built into valuations. Increase in nerves over the quarter meant that Canada could underperformPortugal, Italy, Ireland, and Spain despite being perceived as being in a fundamentally more robust state.

    The strategy is overweight European equities on valuation grounds. Outside of Europe, our policy has ranged from avoid (Canada and Australia are the strategys two most significantgeographical underweights) to invest with caution (in the US, where we retain a significant allocation to high quality blue chips). Overall country selection made a positive contribution toreturns this quarter.

    The strategys stock selection disciplines also contributed to relative returns with the most significant part coming from the allocation to high quality companies unsurprising given the overallnervous tone of the markets. Pharmaceuticals put in the strongest performance of any industry over the period as investors remembered that pharmaceuticals have several desirablecharacteristics, not least the defensive nature of their revenues in the face of concern for the broader economic outlook. The US high quality stocks remain the most significant driver of relativereturns for the strategy at this point.

    The momentum stock picks had relatively little impact as the strategy shifts emphasis away from the Asian-facing growth stocks that allowed us to profit in rising markets last year. We havebeen gradually replacing that exposure with the beneficiaries of rising energy prices in the global oil sector. We have also added to German exporters, such as chemical manufacturer BASF andauto producer Volkswagen, supported by an increasingly competitive exchange rate as a consequence of the trouble in Southern Europe. Overall, energy stocks lagged for the quarter, whilst theGerman exporters added to returns.

    The strategys value discipline outperformed modestly. Given the emphasis on Europe, especially the weaker eurozone members, this was a welcome validation of the philosophy underpinningthis strategy by buying into areas where prices are low, a certain buttressing against unpleasant events is achieved. We continued to refine our valuation-based exposures over the quarter,increasing allocations to the eurozone in general and Spain in particular. We increased our stakes in Santander for example we rate the large Spanish banks as among the better quality andmore diversified large banks in the eurozone today; they trade on reasonable valuations too.

    Prices for European stocks are in many cases significantly lower than those outside Europe. Our principal European investments are in oil companies, auto manufacturers, utilities, andfinancials. We have assembled exposure to integrated oil stocks (for example Italian oil major ENI and Total in France) at an average 30% discount to the global sector. Our investments inautos, utilities, and financials trade on average at discounts of 20-30% to their global peers. This debt crisis, like others before it, has opened windows of opportunity in terms of valuation.

    Total Return Net of Fees (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2011 2011 Year Year Year Inception

    Strategy 1.89 6.66 30.91 1.57 5.68 7.31Benchmark 3 0.47 5.29 30.51 2.28 3.99 5.65

    Annual Total Return Net of Fees (%)

    2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

    Strategy -9.39 -10.70 36.36 17.95 11.08 21.19 6.16 -38.71 24.61 10.40

    Benchmark -16.82 -19 .89 33.11 14.72 9 .49 20.07 9 .04 -40 .71 29.99 11.76

    Johnson & Johnson 3.8%

    Royal Dutch Shell PLC 2.5%

    Coca-Cola Co. 2.3%

    Google Inc. (Cl A) 2.0%

    Apple Inc. 1.9%

    Merck & Co Inc 1.7%

    Wal-Mart Stores Inc. 1.7%

    PepsiCo Inc. 1.7%

    ENI S.p.A. 1.6%

    QUALCOMM Inc. 1.5%

    Total 20.7%

    Strategy Benchmark

    Alpha 2.47 0.00

    Beta 0.91 1.00

    R2

    0.95 1.00

    Sharpe Ratio 0.32 0.16

    Strategy Benchmark

    Price/Earnings - Hist 1 Yr Wtd Med 13.3 x 15.2 x

    Price/Cash Flow- Hist 1 Yr Wtd Med 10.2 x 10.6 x

    Price/Book - Hist 1 Yr Wtd Avg 1.7 x 1.8 x

    Return on Equity - Hist 1 Yr Wtd Med 16.9 % 14.5 %

    Market Cap - Weighted Median $Bil $41.4 $33.7

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.6 %

    Underweight/OverweightRegion Against Benchmark (%)

    North America

    Europe ex-UK

    United Kingdom

    Japan

    Pacific ex-Japan

    Cash 1.7

    -3.2

    0.5

    0.8

    3.4

    -3.3

    -10 -5 0 5 10

    Underweight/Overweight

    Sector Against Benchmark Strategy Benchmark

    Consumer Discretionary 10.5 % 10.5 %Consumer Staples 9.1 9.9Energy 14.3 11.4Financials 12.6 19.6Health Care 16.0 9.8Industrials 11.9 11.5Information Technology 12.1 11.2Materials 6.2 8.2

    Telecom. Services 4.2 4.2Utilities 3.2 3.8-0.6

    0.0

    -2.0

    0.9

    0.4

    6.2-7.0

    2.9

    -0.8

    0.0

    -10 -5 0 5 10

  • 7/31/2019 2q 2011 European Update

    17/47

    GMO European Quarterly Update 17

    As of June 30, 2011

    GMO 2011

    GMO World ex-UK Equity StrategyInception: 12/31/88; Benchmark: FTSE World ex-UK Total Return Index

    Performance (GBP)1

    The World ex-UK Equity Strategy returned +1.0% for the second quarter, outperforming the FTSE World ex-UK Index which returned +0.3% in sterling terms.The strategy is overweight European equities on valuation grounds. Outside of Europe, our policy has ranged from avoid (Canada and Australia are the strategys two

    most significant geographical underweights) to invest with caution (in the U.S., where we retain a significant allocation to high quality blue chips). Overall countryselection made a positive contribution to returns this quarter.

    The strategys stock selection disciplines also contributed to relative returns with the most significant part coming from the allocation to high quality companies unsurprising given the overall nervous tone of the markets. Pharmaceuticals put in the strongest performance of any industry over the period as investors rememberedthat pharmaceuticals have several desirable characteristics, not least the defensive nature of their revenues in the face of concern for the broader economic outlook. TheU.S. high quality stocks remain the most significant driver of relative returns for the strategy at this point.

    The momentum stock picks had relatively little impact as the strategy shifts emphasis away from the Asian-facing growth stocks that allowed us to profit in risingmarkets last year. We have been gradually replacing that exposure with the beneficiaries of rising energy prices in the global oil sector. We have also added to Germanexporters, such as chemical manufacturer BASF and auto producer Volkswagen, supported by an increasingly competitive exchange rate as a consequence of the troublein Southern Europe. Overall, energy stocks lagged for the quarter, whilst the German exporters added to returns.

    The strategys value discipline outperformed modestly. Given the emphasis on Europe, especially the weaker eurozone members, this was a welcome validation of thephilosophy underpinning this strategy by buying into areas where prices are low, a certain buttressing against unpleasant events is achieved. We continued to refine our

    valuation-based exposures over the quarter, increasing allocations to the eurozone in general and Spain in particular. We increased our stakes in Santander for example we rate the large Spanish banks as among the better quality and more diversified large banks in the eurozone today; they trade on reasonable valuations too.Prices for European stocks are in many cases significantly lower than those outside Europe. Our principal European investments are in oil companies, auto

    manufacturers, utilities, and financials. We have assembled exposure to integrated oil stocks (for example Italian oil major ENI and Total in France) at an average 30%discount to the global sector. Our investments in autos, utilities, and financials trade on average at discounts of 20-30% to their global peers. This debt crisis, like othersbefore it, has opened windows of opportunity in terms of valuation.

    Top Ten Holdings2,5

    Risk Profile Since 12/31/954

    Quarterly Strategy Attribution

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3 The FTSE World ex-UK Index is an independently maintained and widely published index comprised of developed (excluding the UK) and emerging large and mid

    capitalization stocks.4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk. Risk profile data is gross.5The above information is based on a representative account selected because it has the least number of restrictions and best represents the implementation of the strategy.The performance information above is supplemental to the GIPS compliant presentation that was made available on GMOs website in April of 2011.

    Sector Weights5

    GICS Sectors

    Regional Weights5

    Characteristics5

    Total Return Net of Fees (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2011 2011 Year Year Year Inception

    Strategy 1.01 3.41 21.43 5.49 4.64 9.25Benchmark 3 0.30 2.59 22.14 6.85 3.77 7.34

    Annual Total Return Net of Fees (%)

    2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

    Strategy -9.49 -21.29 23.70 9.75 25.88 5.41 7.41 -14.80 13.64 13.64

    Benchmark -14.04 -27.35 20.66 7 .83 24.85 5 .65 9 .70 -17.12 18.86 16.69

    Johnson & Johnson 3.8%

    Coca-Cola Co. 2.2%

    Google Inc. (Cl A) 1.8%

    Apple Inc. 1.8%

    ENI S.p.A. 1.8%

    Merck & Co Inc 1.8%

    PepsiCo Inc. 1.6%

    Wal-Mart Stores Inc. 1.6%

    Sanofi -Avent is S.A. 1 .4%

    QUALCOMM Inc. 1.4%

    Total 19.2%

    Strategy Benchmark

    Alpha 1.94 0.00

    Beta 0.84 1.00

    R 0.79 1.00

    Sharpe Ratio 0.20 0.09

    Strategy Benchmark

    Price/Earnings - Hist 1 Yr Wtd Med 13.4 x 15.2 x

    Price/Cash Flow - Hist 1 Yr Wtd Med 10.3 x 10.5 x

    Price/Book - Hist 1 Yr Wtd Avg 1.7 x 1.8 x

    Return on Equity - Hist 1 Yr Med 16.4 % 14.2 %

    Market Cap - Weighted Med GBP Bil. 23.2 18.9

    Dividend Yield - Hist 1 Yr Wtd Avg 2.9 % 2.5 %

    Underweight/Overweighteg on ga ns enc mar

    Europe ex-UK

    North America

    Japan

    Pacific ex-Japan

    Emerging

    Cash 1.3

    1.7

    -3.1

    0.2

    -3.0

    3.0

    -10 -5 0 5 10

    Underweight/OverweightSector Against Benchmark Strategy Benchmark

    Consumer Discretionary 10.6 % 10.8 %

    Consumer Staples 8.6 9.2

    Energy 14.3 9.9

    Financials 13.7 20.5

    Health Care 13.9 8.8

    Industrials 11.6 11.9

    Information Technology 13.3 12.6

    Materials 6.7 8.4

    Telecom. Services 4.0 4.2

    Utilities 3.3 3.6-0.3-0.2

    -1.7

    0.7-0.3

    5.1

    -6.8

    4.4

    -0.6

    -0.2

    -10 -5 0 5 10

  • 7/31/2019 2q 2011 European Update

    18/47

    18 GMO European Quarterly Update

    As of June 30, 2011

    GMO 2011

    GMO International Intrinsic Value StrategyInception: 3/31/87; Benchmark: MSCI EAFE Value Index and MSCI EAFE Index

    Performance (USD)1 Top Ten Holdings2,5

    Risk Profile Since 3/31/874

    Quarterly Strategy Attribution

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3 The MSCI EAFE (Europe, Australasia, and Far East) Value Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely

    published index comprised of international large and mid capitalization stocks that have a value style. Large and mid capitalization stocks encompass approximately 85%of each markets free float-adjusted market capitalization. Style is determined using a multi-factor approach based on historical and forward-looking characteristics. MSCIdata may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk. Risk profile data is gross.

    5 The above information is based on a representative account selected because it has the least number of restrictions and best represents the implementation of the strategy.The performance information above is supplemental to the GIPS compliant presentation that was made available on GMOs website in April of 2011.

    Sector Weights5Regional Weights5

    Characteristics5

    The International Intrinsic Value Strategy returned +2.7% during the second quarter of 2011, compared to the broad market MSCI EAFE index, whichreturned +1.6%, and the MSCI EAFE Value benchmark, which returned +1.0%.

    Stock selection and sector exposures both contributed to the outperformance relative to EAFE. Selection was particularly good within the United Kingdom(especially among high quality drug companies) and Japan (notably among consumer stocks and rebuilding-related stocks). By sector, stock selection was bestin Consumer Discretionary, Health Care, and Utilities.

    Sector exposures (as a result of stock selection) added value mainly from our overweight to Health Care, which was the best performing sector in EAFE.

    In country allocation, the positive impact from our underweight to Australia, which underperformed, was largely offset by the negative impact from ouroverweight to Italy, which also underperformed.

    Compared to the value benchmark, the strategy did even better due to the many differences between EAFE and EAFE Value.

    The EAFE Value index has less in Consumer Staples, which outperformed, and more in Energy, which underperformed, and holds different stocks. These

    resulted in better relative performance from sector exposures and stock selection versus EAFE Value.GMOs stock selection disciplines had good results in the quarter as momentum outperformed value. Stocks selected for their strong momentum

    characteristics had the best returns. Those stocks chosen by quality-adjusted value were next, and those ranked highly by intrinsic value (the quality componentdid very well; valuation did not) trailed. All three disciplines outperformed.

    Individual stock positions that added significant value included overweights in pharmaceuticals Sanofi (France), GlaxoSmithKline (UK), and AstraZeneca(UK). Stock positions that were significant detractors included overweights in oil companies Total (France), Eni (Italy), and Encana (Canada).

    GICS Sectors

    Tota l Retur n Net of Fees (%) Aver age Annua l Tota l Retur n (%)

    2Q YTD One Five Ten Since2011 2011 Year Year Year Inception

    Strategy 2.68 6.94 31.34 0.72 8.13 8.57MSCI EAFE Value 3 0.98 5.58 29.35 0.36 5.96 7.36

    MSCI EAFE3

    1.56 4.98 30.36 1.48 5.66 5.41

    Annual Total Return Net of Fees (%)

    2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

    Strategy -12.10 -0.59 43.53 25.23 13.98 25.78 10.21 -40.31 21.41 7.53MSCI EAFE Value -18.52 -15.91 45.30 24.33 13.80 30.38 5.96 -44.09 34.23 3.25

    MSCI EAFE -21.44 -15.94 38.59 20.25 13.54 26.34 11.17 -43.38 31.78 7.75

    Sanofi-Aventis S.A. 4.3%

    Total S.A. 3.9%

    GlaxoSmithKline PLC 3.3%

    Royal Dutch Shell PLC 3.2%

    AstraZeneca PLC 3.1%

    ENI S.p.A. 2.7%

    Enel S.p.A. 2.2%

    Novartis AG 1.8%

    E.ON AG 1.6%

    Takeda Pharmaceutical 1.5%

    Total 27.6%

    Strategy

    M SCI

    EAFE Val ue

    MSCI

    EAFE

    Alpha 2.58 0.00 0.00

    Beta 0.81 1.00 1.00

    R2

    0.86 1.00 1.00

    Sharpe Ratio 0.33 0.18 0.08

    Strategy

    M SCI

    EAFE Val ue

    MSCI

    EAFE

    Price/Earnings - Hist 1 Yr Wtd Med 11.0 x 11.6 x 14.0 x

    Price/Cash Flow - Hist 1 Yr Wtd Med 6.4 x 6.3 x 9.1 x

    Price/Book - Hist 1 Yr Wtd Avg 1.3 x 1.2 x 1.5 x

    Return on Equity - Hist 1 Yr Med 12.8 % 10.7 % 11.4 %Market Cap - Weighted Median $Bil $29.8 $34.4 $29.3

    Dividend Yield - Hist 1 Yr Wtd Avg 4.1 % 4.4 % 3.4 %

    Underweight/Overweight

    Region Against M SCI EAFE Value (%)

    Europe ex-UK

    United Kingdom

    Japan

    Southeast Asia

    Canada

    Australia/New Zealand

    Cash 1.6

    -6.5

    2.0

    -0.4

    2.8

    0.7

    -0.3

    -10 -5 0 5 10

    Underweight/OverweightSector Against M SCI EAFE Value Strategy Benchmark

    Consumer Discretionary 11.1 % 7.9 %Consumer Staples 3.9 2.7Energy 15.9 11.3Financials 16.1 34.5Health Care 16.5 10.0Industrials 9.8 7.1Information Technology 3.4 2.7Materials 7.8 6.9

    Telecom. Services 8.6 9.4Utilities 6.9 7.5-0.6

    -0.8

    0.9

    0.7

    2.7

    6.5

    -18.4

    4.6

    1.2

    3.2

    -20 -10 0 10 20

  • 7/31/2019 2q 2011 European Update

    19/47

    GMO European Quarterly Update 19

    As of June 30, 2011

    GMO 2011

    GMO International Core Equity StrategyInception: 1/31/02; Benchmark: MSCI EAFE Index

    Performance (USD)1 Top Ten Holdings2,5

    Risk Profile Since 1/31/024

    Quarterly Strategy Attribution

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3 The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published

    index comprised of international large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, hasnot prepared or approved this report, and has no liability hereunder.

    4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk. Risk profile data is gross.

    5 The above information is based on a representative account selected because it has the least number of restrictions and best represents the implementation of the strategy.The performance information above is supplemental to the GIPS compliant presentation that was made available on GMOs website in April of 2011.

    Sector Weights5

    GICS Sectors

    Regional Weights5

    Characteristics5

    The International Core Equity Strategy returned +3.5% during the second quarter of 2011, compared to the MSCI EAFE index, which returned+1.6%.

    Stock selection and sector exposures both contributed to the outperformance relative to EAFE.

    Stock selection was particularly good within the United Kingdom (especially among high quality drug companies), Japan (notably among consumerstocks and rebuilding-related stocks), and France (in drug and chemical companies). By sector, stock selection was best in Consumer Discretionary,Health Care, and Utilities.

    Sector exposures (as a result of stock selection) added value mainly from our overweight to Health Care, which was the best performing sector inEAFE, and underweight to Financials, which underperformed.

    In country allocation, the positive impact from our underweight to Australia, which underperformed, was largely offset by the negative impact fromour overweight to Italy, which also underperformed.

    GMOs stock selection disciplines had good results in the quarter as momentum outperformed value. Stocks selected for their strong momentumcharacteristics had the best returns. Those stocks chosen by quality-adjusted value were next, and those ranked highly by intrinsic value (the qualitycomponent did very well; valuation did not) trailed. All three disciplines outperformed.

    Individual stock positions that added significant value included overweights in pharmaceuticals Sanofi (France) and GlaxoSmithKline (UK) andchemical company Rhodia (France). Stock positions that were significant detractors included overweights in oil companies Encana (Canada), Total(France), and Eni (Italy).

    Total Return Net of Fees (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2011 2011 Year Year Year Inception

    Strategy 3.51 7.31 34.25 1.74 n/a 9.33Benchmark 3 1.56 4.98 30.36 1.48 n/a 7.59

    Annual Total Return Net of Fees (%)

    2002 2003 2004 2005 2006 2007 2008 2009 2010

    Strategy -2.43 37.67 23.28 15.58 25.56 12.13 -41.34 23.73 10.33

    Benchmark -11.22 38.59 20.25 13.54 26.34 11.17 -43 .38 31.78 7 .75

    Sanofi-Aventis S.A. 3.6%

    GlaxoSmithKline PLC 3.3%

    Total S.A. 3.0%

    Royal Dutch Shell PLC 2.9%

    AstraZeneca PLC 2.7%

    ENI S.p.A. 2.5%

    Novartis AG 1.9%

    Enel S.p.A. 1.8%

    Vodafone Group PLC 1.4%

    Takeda Pharmaceutical 1.4%

    Total 24.5%

    Strategy Benchmark

    Alpha 2.57 0.00

    Beta 0.94 1.00

    R2

    0.98 1.00

    Sharpe Ratio 0.45 0.31

    Strategy Benchmark

    Price/Earnings - Hist 1 Yr Wtd Med 11.8 x 14.0 x

    Earnings/Share - F'cast LT Med Growth Rate 8.8 x 10.2 x

    Price/Book - Hist 1 Yr Wtd Avg 1.4 x 1.5 x

    Return on Equity - Hist 1 Yr Med 12.5 % 11.4 %

    Market Cap - Weighted Median $Bil $28.5 $29.3Dividend Yield - Hist 1 Yr Wtd Avg 3.8 % 3.4 %

    Underweight/Overweight

    Region Against Benchmark (%)

    Europe ex-UK

    United Kingdom

    Japan

    Southeast Asia

    Canada

    Australia/New Zealand

    Cash 0.7

    -5.1

    1.2

    -0.3

    2.8

    -0.6

    1.2

    -10 -5 0 5 10

    Underweight/OverweightSector Against Benchmark Strategy Benchmark

    Consumer Discretionary 13.1 % 10.5 %Consumer Staples 5.1 10.2Energy 13.5 8.1Financials 12.1 23.5Health Care 16.1 8.7Industrials 11.6 12.9Information Technology 5.0 4.7Materials 9.2 11.3

    Telecom. Services 8.3 5.5Utilities 5.9 4.71.22.8

    -2.1

    0.3

    -1.3

    7.4

    -11.4

    5.4

    -5.1

    2.6

    -20 -10 0 10 20

  • 7/31/2019 2q 2011 European Update

    20/47

    20 GMO European Quarterly Update

    As of June 30, 2011

    GMO 2011

    GMO Japan Equity StrategyInception: 12/31/05; Benchmark: MSCI Japan IMI ++ Index

    Performance (USD)1

    The Japan Equity Strategy returned +3.4% during the second quarter of 2011. This was ahead of its benchmark, the MSCI Japan IMIindex, which returned +0.5%.

    Within the portfolio, stock selection and the resulting sector exposures were the primary reasons for the outperformance.

    Performance was particularly good within Consumer Discretionary, but also within Telecommunication Services, Financials, andMaterials.

    Individual stock positions that added value included overweight positions in telecom company KDDI Corp., real estate developer

    Daito Trust Construction, and leisure company Round One Corp. Stock positions that were significant detractors includedunderweights in office electronics company Canon, machinery company Fanuc, and electronics company Hitachi.

    Sector exposures also added some value, thanks to our overweight to Telecommunication Services, which outperformed, and ourunderweight to Utilities, which lagged.

    Top Ten Holdings2,5

    Risk Profile Since 12/31/054

    Quarterly Strategy Attribution

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3 The MSCI Japan IMI (Investable Market Index Series) ++ Index is an internally maintained benchmark computed by GMO, comprised of (i) the MSCI Japan (MSCI

    Standard Index Series, net of withholding tax) from 12/31/2005 to 6/30/2008 and (ii) the MSCI Japan IMI (MSCI Standard Index Series, net of withholding tax)thereafter. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liabilityhereunder.

    4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk. Risk profile data is gross.

    5 The above information is based on a representative account selected because it has the least number of restrictions and best represents the implementation of the strategy.The performance information above is supplemental to the GIPS compliant presentation that was made available on GMOs website in April of 2011.

    Sector Weights5

    Strategy Benchmark

    Alpha 2.84 0.00

    Beta 1.09 1.00

    R2

    0.94 1.00

    Sharpe Ratio -0.13 -0.29

    Strategy Benchmark

    % Negative Earnings 5.8 % 4.3 %

    Price/Earnings - Excl Neg Earn Hist 1 Yr Wtd Med 10.1 x 16.1 x

    Price/Earnings - Hist 1 Yr Wtd Med 10.4 x 16.7 x

    Price/Book - Hist 1 Yr Wtd Avg 0.8 x 1.0 x

    Return on Equity - Hist 1 Yr Med 8.1 % 6.7 %

    Market Cap - Weighted Median $Bil $2.2 $10.1

    Dividend Yield - Hist 1 Yr Wtd Avg 2.6 % 1.9 %

    Characteristics5

    GICS Sectors

    Total Return Net of Fees (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2011 2011 Year Year Year Inception

    Strategy 3.41 1.85 21.15 -1.14 n/a -0.88Benchmark 3 0.48 -3.97 13.43 -3.24 n/a -2.62

    Annual Total Return Net of Fees (%)

    2006 2007 2008 2009 2010

    Strategy 6.39 -2.39 -24.83 -1.78 21.95

    Benchmark 6 .24 -4 .23 -28 .16 6 .12 16.02

    KDDI Corp. 4.9%

    Mizuho Financial Group 4.1%

    Nippon T & T Corp. 4.0%

    NTT DoCoMo Inc. 3.1%

    Sumitomo Mitsui Financial 2.5%

    Daito Trust Construct ion 2.3%

    Yamada Denki Co. Ltd. 1.8%

    Resona Holdings Inc. 1.8%

    Takeda Pharmaceutical Co. 1.7%

    Sumitomo Corp. 1.3%

    Total 27.5%

    Underweight/OverweightSector Against Benchmark Strategy Benchmark

    Consumer Discretionary 18.2 % 20.0 %Consumer Staples 7.9 5.9Energy 4.1 1.6Financials 21.2 17.2Health Care 4.8 5.8Industrials 19.5 21.0

    Information Technology 3.7 12.8Materials 6.7 8.6Telecom. Services 12.1 3.8Utilities 1.9 3.3-1.4

    8.3

    -1.9

    -9.1-1.5

    -1.0

    4.0

    2.5

    2.0

    -1.8

    -10 -5 0 5 10

  • 7/31/2019 2q 2011 European Update

    21/47

    GMO European Quarterly Update 21

    As of June 30, 2011

    GMO 2011

    GMO Emerging Markets StrategyInception: 12/31/93; Benchmark: S&P/IFCI Composite Index

    Performance (USD)1

    The Emerging Markets Strategy fell 1.5% in the second quarter, trailing the -1.0% return of the S&P/IFCI Composite by 0.5%. Overall, country/sector selection detracted0.1%, while stock selection cost 0.4%.

    Emerging markets suffered minor losses over the second quarter as investors chewed over the myriad developments in the sovereign debt crisis and the pace of monetarytightening in several key markets. The last days of the quarter saw sentiment turn bullish as concern of a Greek default eased after the government secured enough votes topush ahead with budget cuts. The quarter saw country performances as diverse as an 8.5% jump in Chile and a 15.2% plunge in Peru. Among sectors, the spread was tighter,

    with Consumer Discretionary leaping 8.3% and Energy dropping 7.4%.Russian Energy underperformed the asset class as the outlook for commodities grew less rosy and concern deepened that tighter monetary policy in Russia would curb

    economic growth. The central bank unexpectedly raised interest rates in April to check inflation. The concerns over the ultimate resolution to Greeces debt crisis, inflationfighting efforts in countries such as China and India, and speculation that U.S. demand may be slowing have all led to a fall in energy prices. Our overweight in RussianEnergy, a reflection of its cheapness and positive momentum, detracted from performance.

    Investors in Hungary found comfort in the ongoing talks between the government and commercial banks on ending a moratorium on evictions and stimulating mortgagelending. The market was also influenced by rumors that the government would lower a special tax on banks as part